Elisabeth André‐Garnier

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Slim Fourati, Charlotte Charpentier, Corinne Amiel et al. · Journal of Antimicrobial Chemotherapy · 2015 · 58 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial

Laurent Hocqueloux, François Raffi, Thiérry Prazuck et al. · Clinical Infectious Diseases · 2018 · 58 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011

Diane Descamps, Lambert Assoumou, Marie‐Laure Chaix et al. · Journal of Antimicrobial Chemotherapy · 2013 · 51 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

Lise Cuzin, Pascal Puglièse, Christine Katlama et al. · Journal of Antimicrobial Chemotherapy · 2018 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Charlotte Charpentier, Isabelle Malet, Elisabeth André‐Garnier et al. · Journal of Antimicrobial Chemotherapy · 2017 · 46 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +16